SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is a top trending stock after receiving FDA approval for its oral Wegovy pill, a development widely regarded by the community as a significant game-changer in the weight-loss market. Investors are keenly discussing the pill's potential advantages over injectable treatments and its impact on NVO's valuation compared to competitors like Eli Lilly, though some 'sell the news' sentiment is also present.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

Rage Crypto is trending with its passionate community rallying around the "OG meme" status and active efforts to expand the Rage Comics lore, including RageGames tournaments and the revival of ragemaker.net. Investors express strong conviction that the project is undervalued, aiming to onboard a million users and positioning itself for significant growth within the broader crypto market.

Starfighters Space Inc

Starfighters Space (FJET), a recent aerospace IPO utilizing F-104 jets for satellite launches, is experiencing extreme volatility and trending due to its low float and association with the currently hot space sector. The community is actively debating its "parabolic moves" and potential for massive gains, drawing comparisons to other high-flying stocks, though significant concerns about its early-stage business model and "pump and dump" risks are also widely discussed.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2025 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is actively trending amidst significant acquisition speculation, driven by reports that Apollo-backed Legendary is weighing a takeover. The community is buzzing with discussions about various potential suitors, including major streaming players, recognizing Lionsgate's valuable film and television library as a key asset in the ongoing media consolidation landscape.

TOSHI

TOSHI is actively discussed as community members seize recent pullbacks as prime accumulation opportunities, reinforcing strong conviction in its long-term potential as the "Face of Base." Amid chatter regarding new exchange listings and upcoming utility projects like Toshi Mobile, many anticipate a significant upward move for the "blue cat," considering it currently oversold.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to recent drill results indicating significant high-grade silver in its Vortex system, fueling strong community discussion about its long-term potential. Amid a favorable environment for precious metals, the stock is drawing fervent bullish sentiment, notably from those tracking substantial institutional investments, though some express skepticism regarding its operational readiness and short-term volatility.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending due to renewed confidence in its AI Platform (AIP), driven by accelerating commercial adoption and continued integration into government defense programs, including new shipbuilding and drone initiatives. The community is actively celebrating strong performance, with many noting bullish technicals and significant discussion around short positions facing pressure, solidifying its perception as a leading AI and data analytics provider.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending as Oracle founder Larry Ellison has personally guaranteed over $40 billion in equity financing for its all-cash offer to acquire Warner Bros. Discovery, directly addressing prior financial certainty concerns. This significantly strengthens PSKY's bid, with the community actively debating whether WBD's board can continue to favor Netflix's offer amidst mounting regulatory scrutiny and perceived shareholder disadvantages. The move reshapes the ongoing media industry battle, with many seeing PSKY's proposal as a now-superior path for WBD shareholders.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending intensely as the community reacts to Novo Nordisk's recent oral GLP-1 FDA approval, largely perceiving it as a significant de-risking event for the broader oral weight-loss market. Investors are actively comparing VKTX's VK2735 oral and injectable programs against new data from rivals like Eli Lilly, highlighting its potential for best-in-class efficacy with a more favorable tolerability profile amidst discussions of competitor side effects. This dynamic, coupled with anticipation around VKTX's oral VK2735 FDA meeting and the upcoming J.P. Morgan conference, is fueling widespread speculation about major partnerships or an acquisition.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending following the recent Anthony Joshua victory over Jake Paul, an outcome that reportedly saved the sportsbook from nearly $100 million in potential payouts. Concurrently, the launch of its new DraftKings Predictions platform is a major talking point, with the community assessing its potential to expand market reach into new states and compete against other prediction market operators. This strategic move, alongside favorable NFL outcomes boosting Q4 performance, positions DraftKings amid an evolving regulatory landscape and intense competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ENDRAs TAEUS Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in thermo-acoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced new...

ENDRA Feasibility Study Demonstrates TAEUS Accurately Quantifies Liver Fat Fraction, a Key MASLD/MASH Biomarker

ENDRA Life Sciences Inc. (NASDAQ: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction-associated liver disease...

ENDRA Life Sciences Recaps Major Milestones and New Strategic Initiatives, Announces Third Quarter 2025 Financial Results

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in biomarker imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease...

ENDRA Life Sciences Commences Staking of HYPE Digital Asset Holdings, Reinforcing Long-Term Strategy with Anchorage Digital and ARCA

ENDRA Life Sciences Inc. (Nasdaq: NDRA) (ENDRA or the Company), a pioneer in imaging technologies for the early detection and monitoring of metabolic dysfunction associated liver disease (MASLD) and...

ENDRA Life Sciences Closes Up to $14.4 Million Private Placement and Launches Crypto Treasury Strategy with $3 Million in Initial HYPE Token Holdings

Merit Medical Expands GI Portfolio With $22M C2 CryoBalloon Acquisition

MMSI is set to acquire C2 CryoBalloon from Pentax for $22M, strengthening its GI portfolio. Despite near-term dilution, the deal positions Merit for long-term growth in gastroenterology.

ENDRA Life Sciences (NDRA) on Monday announced an aggregate of $4.9 million in commitments for a private placement, which was led by institutional and cryptocurrency investors.The investors have agreed to buy 744,340 shares of common stock or prefunded warrants, and accompanying warrants under the agreement, Endra said. If all warrants are fully exercised for cash, the company will receive up to $14.4 million in proceeds, it said. The offering is expected to close on or about October 14. &nbsp;The proceeds of the placement will be used to launch a digital asset treasury strategy managed by digital asset manager Arca Investment Management, the company said. ENDRA also intends to accumulate cryptocurrency and complete the TAEUS pilot validation imaging study focused on certain chronic liver conditions. Thermo Acoustic Enhanced UltraSound, or TAEUS, is a technology being developed by the company to assess tissue fat content and monitor tissue ablation during minimally invasive procedures.The company also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20251013346843/en/ENDRA-Life-Sciences-Announces-At-Market-Private-Placement-of-Up-to-%2414.4-Million-to-Launch-Digital-Asset-Treasury-Strategy-Managed-by-Leading-Crypto-Asset-Manager-Arca">announced</a> on Monday that it intends to add Arca’s Chief Investment Officer, Jeff Dorman, to its Digital Asset Advisory Board. The firm believes its new digital asset treasury strategy can compound returns and create flexible income to reinvest into cryptocurrency.<a href="https://stocktwits.com/symbol/NDRA">NDRA shares</a> traded 24% higher at the time of writing. On Stocktwits, retail sentiment around the stock rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.NDRA stock is up by 28% this year and by 10% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-tvardi-therapeutics-stock-plummet-pre-market/ch6SK9gR3ki">Why Did Tvardi Therapeutics Stock Plummet 87% Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

What’s Driving The Rally In NDRA Stock Today?

The company announced $4.9 million in commitments for a private placement led by institutional and cryptocurrency investors to be used to launch a digital asset treasury strategy.

Equity

The company announced $4.9 million in commitments for a private placement led by institutional and cryptocurrency investors to be used to launch a digital asset treasury strategy.


Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.

ENDRA Life Sciences Announces At-Market Private Placement of Up to $14.4 Million to Launch Digital Asset Treasury Strategy Managed by Leading Crypto Asset Manager Arca

ENDRA Life Sciences, Inc. engages in the development of medical devices for accurate liver fat measurement for use in metabolic disease detection and GLP-1 drug eligibility and management. The company was founded on July 18, 2007 and is headquartered in Ann Arbor, MI.

Current Price	$5.22
Prev Close	$5.16
Open	$5.29
Dividend Yield	0.00%
50-Day Moving Average	$5.72
Beta	1.40
Avg. Volume	68,109.47
PE Ratio	-0.39

52-Week High	$11.96
52-Week Low	$2.90
Market Capitalization	$6.02M
EPS (Annual)	-$56.94
Price to Book	23.97
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

NDRA
ENDRA Life Sciences Inc

Feed

News

Sentiment

Fundamentals

Info

Latest NDRA News

NDRAENDRA Life Sciences Inc